Expression Patterns of CD44 and AREG Under Treatment With Selective Tyrosine Kinase Inhibitors in HPV+ and HPV- Squamous Cell Carcinoma

Conclusion: The selective drug treatment options significantly influenced the expression of CD44 and AREG in HPV– and HPV+ tumor cells, constituting the need for personalized treatment options.

Source: Cancer Genomics and Proteomics - August 27, 2020 Category: Cancer & Oncology Authors: KANSY, B., ADERHOLD, C., HUBER, L., LUDWIG, S., BIRK, R., LAMMERT, A., LANG, S., ROTTER, N., KRAMER, B. Tags: Experimental Studies Source Type: research